Ordaos Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
25
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$337K
- Investors
-
16
Ordaos General Information
Description
Operator of a human-enabled machine-driven drug design company intended for biomedical research and drug discovery. The company's platform provides an artificial intelligence drug discovery pipeline for researchers to develop novel immunotherapies in oncology and chronic inflammatory disease, enabling medical practitioners to deliver safer and more effective treatments than traditional discovery methods.
Contact Information
Website
www.ordaos.bioCorporate Office
- 228 Park Avenue South
- Suite 60684
- New York, NY 10003
- United States
Corporate Office
- 228 Park Avenue South
- Suite 60684
- New York, NY 10003
- United States
Ordaos Timeline
Ordaos Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 01-Apr-2025 | $337K | Completed | Generating Revenue | ||
| 4. Seed Round | 01-Nov-2024 | Completed | Startup | |||
| 3. Accelerator/Incubator | 31-Mar-2023 | Completed | Startup | |||
| 2. Seed Round | 25-Aug-2022 | $10.7M | $10.7M | Completed | Startup | |
| 1. Accelerator/Incubator | Completed | Startup |
Ordaos Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-4 | ||||||||
| Seed-3 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Ordaos Comparisons
Industry
Financing
Details
Ordaos Competitors (40)
One of Ordaos’s 40 competitors is Cyrus Biotechnology, a Venture Capital-Backed company based in Seattle, WA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cyrus Biotechnology | Venture Capital-Backed | Seattle, WA | ||||
| AI Proteins | Venture Capital-Backed | Boston, MA | ||||
| BigHat Biosciences | Venture Capital-Backed | San Mateo, CA | ||||
| AbCellera Biologics | Formerly VC-backed | Vancouver, Canada | ||||
| Verge Labs | Venture Capital-Backed | San Francisco, CA |
Ordaos Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Ordaos Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Ordaos Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 2468 Ventures | Venture Capital | Minority | ||
| BioAdvance Capital (Conshohocken) | Venture Capital | Minority | ||
| Lunch Pail Ventures | Angel Group | Minority | ||
| NuFund Venture Group | Angel Group | Minority | ||
| AWS Startups | Accelerator/Incubator |
Ordaos Investments (1)
Ordaos’s most recent deal was a Seed Round with Quercus Biosolutions for . The deal was made on 22-Aug-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Quercus Biosolutions | 22-Aug-2025 | Seed Round | Agricultural Chemicals |
Ordaos FAQs
-
When was Ordaos founded?
Ordaos was founded in 2019.
-
Where is Ordaos headquartered?
Ordaos is headquartered in New York, NY.
-
What is the size of Ordaos?
Ordaos has 25 total employees.
-
What industry is Ordaos in?
Ordaos’s primary industry is Drug Discovery.
-
Is Ordaos a private or public company?
Ordaos is a Private company.
-
What is Ordaos’s current revenue?
The current revenue for Ordaos is .
-
How much funding has Ordaos raised over time?
Ordaos has raised $24.5M.
-
Who are Ordaos’s investors?
2468 Ventures, BioAdvance Capital (Conshohocken), Lunch Pail Ventures, NuFund Venture Group, and AWS Startups are 5 of 16 investors who have invested in Ordaos.
-
Who are Ordaos’s competitors?
Cyrus Biotechnology, AI Proteins, BigHat Biosciences, AbCellera Biologics, and Verge Labs are some of the 40 competitors of Ordaos.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
